| Cat. No. | Product Name | Inquiry |
|---|---|---|
| X23-10-ZQ513 | IL receptor inhibitor Suplatast tosilate, Purity ≥98% | |
| X23-10-ZQ521 | IRAK inhibitor 3, Purity ≥98% | |
| X23-10-ZQ543 | IL receptor inhibitor Y320, Purity ≥98% | |
| X23-10-ZQ585 | IL receptor inhibitor MCC950 sodium, Purity ≥98% | |
| X23-10-ZQ588 | IL receptor inhibitor SC-144, Purity ≥98% | |
| X23-10-ZQ591 | IL receptor inhibitor Apilimod, Purity ≥98% | |
| X23-10-ZQ617 | IL receptor inhibitor beta-Interleukin I (163-171), Purity ≥98% | |
| X23-10-ZQ631 | IL receptor antagonist YM-90709, Purity ≥98% | |
| X23-10-ZQ636 | IL receptor inhibitor APY0201, Purity ≥98% | |
| X23-10-ZQ644 | IL receptor inhibitor AS101, Purity ≥98% | |
| X23-10-ZQ662 | IL receptor antagonist AF 12198, Purity ≥98% |
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.